Amgen’s stock falls 4% as analysts say drug updates lag competitors

The biotech offered an update on two drugs in development, but analysts said they’re not as effective as existing treatments.
Article Attribution | Read More at Article Source
The post Amgen’s stock falls 4% as analysts say drug updates lag competitors appeared first on RocketNews.